Skip to content
Screener

Biote Corp. BTMD Q1 2026 earnings

Reported May 6, 2026 · After market close

Revenue$44.9MMiss by $1.1M
EPS$0.06Miss by $0.03
Revenue estimate$46.0M
EPS estimate$0.09

Next report

Nov 4, 2026 (In 3 weeks)
Revenue estimate$44.0M
EPS estimate-$0.05

Financials

Q1 2026

Income statement

See full
Revenue$44.9M-8.3%
Gross profit$31.0M-14.9%
Operating income$3.2M-67.3%
Net income$2.3M-83.4%
EPS (diluted)$0.06-83.8%

Balance sheet

See full
Cash & equivalents$5.3M-87.2%
Total debt$103.4M-5.5%
Total equity-$56.1M+37.7%
Total assets$89.0M-27.8%

Cash flow

See full
Operating cash flow$3.9M-39.7%
CapEx$362.0K-77.8%
Free cash flow$3.5M-26.8%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$41.46M-60.5%
Enterprise value$139.57M-19.1%
P/E2.7×-2.3×
P/S0.2×-0.3×

Profitability

See full
Gross margin70.1%-1.2pp
Operating margin15.4%-0.1pp
Net margin8.3%-2.3pp
FCF margin15.3%-3.2pp

Returns & leverage

See full
Current ratio1.3×-0.1×

Segments

By product

See full
Product Revenue$43.9M-6.7%
Pellet Procedures Product Revenue$31.3M-13.2%
Dietary Supplements$11.0M+19.1%
Disposable Trocars Product Revenue$1.1M-3.8%
Other Service Revenue$578.0K-55.7%

FAQ

When did Biote Corp. report Q1 2026 earnings?
Biote Corp. (BTMD) reported Q1 2026 earnings on May 6, 2026 after market close.
What were Biote Corp.'s Q1 2026 revenue and EPS?
Biote Corp. reported revenue of $44.9M and eps of $0.06 for Q1 2026.
Did Biote Corp. beat estimates in Q1 2026?
Revenue missed the consensus estimate of $46.0M by $1.1M. EPS missed the consensus estimate of $0.09 by $0.03.
How did Biote Corp.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 8.3% from $49.0M a year earlier and eps declined 25.0% from $0.08.
Where can I find Biote Corp.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-208965) and the 10-Q periodic report (0001193125-26-216780) directly on SEC EDGAR. The filing index links above go to sec.gov.